Cytokinetics Stock Price on June 26, 2022 Breakdown

CYTK
 Stock
  

USD 49.47  0.83  1.65%   

As of today, the current price of Cytokinetics is  49.47 , as last reported on the 14th of August 2022, with the highest price reaching  52.48  and the lowest price hitting  48.92  during the day.
Cytokinetics appears to be very steady, given 3 months investment horizon. Cytokinetics secures Sharpe Ratio (or Efficiency) of 0.073, which signifies that the company had 0.073% of return per unit of risk over the last 3 months. Our standpoint towards foreseeing the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Cytokinetics, which you can use to evaluate the future volatility of the firm. Please makes use of Cytokinetics' Mean Deviation of 3.5, risk adjusted performance of 0.1482, and Downside Deviation of 5.7 to double-check if our risk estimates are consistent with your expectations.
  
The current Net Income Common Stock is estimated to decrease to about (221 M). Cytokinetics Price to Book Value is increasing as compared to previous years. The preceding year's Price to Book Value was reported at 15.68. The current Price to Sales Ratio is estimated to increase to 53.69, while Price to Earnings Ratio are projected to decrease to (16.71) . Cytokinetics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Most Recent Activity

Shares Float
93.5 M
Shares Outstanding
94.1 M
Shares Short Prior Month
11.8 M
Earnings Share
-3.21
Shares Short
11.7 M
Revenue Per Share
1.8

Cytokinetics Main Headline on 23rd of June 2022

Cytokinetics Hopes to Emulate Vertexs Market Success, Share Price Gains GuruFocus.com

Cytokinetics Valuation on June 26, 2022

It is possible to determine the worth of Cytokinetics on a given historical date. On June 26, 2022 Cytokinetics was worth 43.23 at the beginning of the trading date compared to the closed value of 47.47. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cytokinetics stock. Still, in general, we apply an absolute valuation method to find Cytokinetics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Visa where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cytokinetics' related companies.
 Open High Low Close Volume
  42.19    44.54    41.69    42.97    775,259  
06/23/2022
  43.23    47.48    43.23    47.47    1,192,027  
  47.98    48.10    45.25    47.25    1,271,809  
Backtest Cytokinetics  |  Cytokinetics History  |  Cytokinetics Valuation   PreviousNext  
Open Value 43.23
47.47
Closing Value
57.78
Upside

Cytokinetics Trading Date Momentum on June 26, 2022

On June 24 2022 Cytokinetics was traded for  47.25  at the closing time. The top price for the day was 48.10  and the lowest listed price was  45.25 . The trading volume for the day was 1.3 M. The trading history from June 24, 2022 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.46% . The overall trading delta against the current closing price is 14.81% .

Cytokinetics Fundamentals Correlations and Trends

By evaluating Cytokinetics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cytokinetics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cytokinetics financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Cytokinetics Stock history

Cytokinetics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cytokinetics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cytokinetics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cytokinetics historical stock prices may prove useful in developing a viable investing in Cytokinetics
Last ReportedProjected for 2022
Weighted Average Shares76.9 M65.4 M
Weighted Average Shares Diluted76.9 M65.6 M
Issuance Purchase of Equity Shares320 M345.2 M
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company was incorporated in 1997 and is headquartered in South San Francisco, California. Cytokinetics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 253 people.

Cytokinetics Quarterly Market Capitalization

3.37 Billion

Cytokinetics Stock Technical Analysis

Cytokinetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cytokinetics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cytokinetics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Cytokinetics Period Price Range

Low
June 23, 2022
High

 43.23 

  

 47.47 

4.249.81%

Cytokinetics August 14, 2022 Market Strength

Market strength indicators help investors to evaluate how Cytokinetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cytokinetics shares will generate the highest return on investment. By undertsting and applying Cytokinetics stock market strength indicators, traders can identify Cytokinetics entry and exit signals to maximize returns

Cytokinetics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Cytokinetics stock's direction in advance. Along with the technical and fundamental analysis of Cytokinetics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cytokinetics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Continue to Trending Equities. Note that the Cytokinetics information on this page should be used as a complementary analysis to other Cytokinetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Cytokinetics Stock analysis

When running Cytokinetics price analysis, check to measure Cytokinetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytokinetics is operating at the current time. Most of Cytokinetics' value examination focuses on studying past and present price action to predict the probability of Cytokinetics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytokinetics' price. Additionally, you may evaluate how the addition of Cytokinetics to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Is Cytokinetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
4.7 B
Quarterly Revenue Growth YOY
30.29
Return On Assets
-0.17
Return On Equity
-3.38
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine Cytokinetics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.